CELL SOURCE, INC. Third Amended and RestatedCell Source, Inc. • August 12th, 2021 • Pharmaceutical preparations • New York
Company FiledAugust 12th, 2021 Industry JurisdictionThis Third Amended and Restated Convertible Note (the “Note”) is issued by Cell Source, Inc., a Nevada corporation (the “Company”), effective as of the 18th day of June, 2021 (the “Issuance Date”), to Darlene D. Soave (the “Lender”) pursuant to the exemptions from registration under the Securities Act of 1933, as amended, and amends and restates the 8% Convertible Note issued by the Company to the Lender effective as of October 28, 2019, as amended by the Amended and Restated 8% Convertible Note dated June 18, 2020 and effective as of October 28, 2019, as amended by Amendment No. 1 thereto dated as of December 3, 2020, and as amended by the Amended and Restated Note dated March 2, 2021 (collectively, the “Original Note”).